3 completed, 3 terminated, 2 not yet recruiting, 1 recruiting. 4 Phase 4, 3 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Not yet recruiting 2, Terminated 2 |
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Erysipelas: new trials by email Literature Review of Erysipelas trials Research Report on Erysipelas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylaxis of Recurrent Erysipelas in Lower Limbs: compreSsion thErapy vs aNTibiotics and Compression Therapy. elastic stockings, Phenoxymethylpenicillin - Recurrent Erysipelas | Phase 4 | Not yet recruiting | University Hospital, Tours | 200 | 2026-04-01 | 2026-04-24 |
| Comparing Short to Standard Amoxicillin Course for Erysipelas Course of amoxicillin - Erysipelas | Phase 4 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 656 | 2026-01-01 | 2025-08-12 |
| Hospital at Home for Elderly Acute Ill Patients Hospital at Home (HaH) treatment, Standard hospital admission - Cystitis, Erysipelas | Not applicable | Recruiting | Defactum, Central Denmark Region | 849 | 2022-06-01 | 2024-08-09 |
| Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever Musculoskeletal ultrasound - Erysipelas | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 15 | 2019-05-01 | 2019-04-17 |
| Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study Tedizolid (Sivextro, BAY1192631), Linezolid - Skin Disease, Infectious | Terminated | Bayer | 108 | 2016-12-17 | 2019-10-02 | |
| Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo Screening, Tele-dermatology - Erysipelas, Impetigo | Not applicable | Completed | Centro Studi Gised | 461 | 2016-10-01 | 2019-05-17 |
| Duration of ANtibiotic Therapy for CEllulitis Flucloxacillin, Placebo (for flucloxacillin) - Cellulitis, Erysipelas | Phase 4 | Terminated | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 151 | 2014-08-26 | 2017-10-10 |
| Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections Daptomycin, Brilacidin - Skin Infection, Bacterial Infection | Phase 2 | Completed | Cellceutix Corporation | 215 | 2014-02-01 | 2018-09-26 |
| A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study TR701 FA - Major Cutaneous Abscess, Cellulitis | Phase 2 | Completed | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 200 | 2012-02-15 | 2018-08-29 |
| Short Course of Amoxicillin for Erysipelas Amoxicillin - Erysipelas | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 10 | 2010-09-01 | 2014-02-07 |
| The Use of Oral Steroids in the Treatment of Cellulitis Prednisone, Placebo Oral Tablet - Cellulitis, Erysipelas | Phase 2 | Withdrawn | Milton S. Hershey Medical Center | 2010-01-15 | 2017-07-25 |
Cellulitis (5) · Abscess (2) · Wound Infection (2) · Alzheimer Disease (1) · Bacterial Infections (1) · Carcinoma, Basal Cell (1) · Carcinoma, Squamous Cell (1) · Cystitis (1) · Familial Mediterranean Fever (1) · Herpes Zoster (1) · Impetigo (1) · Keratosis, Actinic (1) · Melanoma (1) · Molluscum Contagiosum (1)
Bacterial Infections and Mycoses (11) · Gram-Positive Bacterial Infections (11) · Infections (11) · Skin Diseases (11) · Skin Diseases, Bacterial (11) · Skin and Connective Tissue Diseases (11) · Streptococcal Infections (11) · Bacterial Infections (10) · Skin Diseases, Infectious (10) · Connective Tissue Diseases (5) · Inflammation (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Suppuration (5) · Brain Diseases (1)
tedizolid (2) · Amoxicillin (1) · Daptomycin (1) · Floxacillin (1) · Linezolid (1) · Mass Screening (1) · Penicillin V (1) · Prednisone (1) · Stockings, Compression (1) · Therapeutics (1) · brilacidin (1) · tedizolid phosphate (1)
Assistance Publique - Hôpitaux de Paris (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Bayer (1) · Cellceutix Corporation (1) · Centro Studi Gised (1) · Defactum, Central Denmark Region (1) · Milton S. Hershey Medical Center (1) · Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · University Hospital, Tours (1)
France (3) · United States (2) · Denmark (1) · Italy (1) · Mexico (1) · Netherlands (1) · Russia (1) · Singapore (1)
France Guyot (1) · Jan M. Prins, MD, PhD (1) · Luigi Naldi, MD (1) · Philippe Prokocimer, MD (1) · Scott Goldstein, DO (1) · W. Joost Wiersinga, MD, PhD (1) · William O'Riordan, MD (1)
PMID 24885384, PMID 27530088, PMID 30321312, PMID 38697766, PMID 42009379
2008 (1)